133 related articles for article (PubMed ID: 9449204)
1. Expression of aromatase cytochrome P450 in rat H540 Leydig tumor cells.
Young M; Lephart ED; McPhaul MJ
J Steroid Biochem Mol Biol; 1997; 63(1-3):37-44. PubMed ID: 9449204
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytochrome P-450(17) alpha, 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase, and steroid 5 alpha-reductase in rat H540 Leydig tumor cells.
Mack SO; Lorence MC; Andersson S; Mason JI
Mol Cell Endocrinol; 1990 Dec; 74(3):R11-7. PubMed ID: 2095353
[TBL] [Abstract][Full Text] [Related]
3. A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines.
Young M; McPhaul MJ
Endocrinology; 1998 Dec; 139(12):5082-93. PubMed ID: 9832447
[TBL] [Abstract][Full Text] [Related]
4. Diverse mechanisms of control of aromatase gene expression.
McPhaul MJ; Herbst MA; Matsumine H; Young M; Lephart ED
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):341-6. PubMed ID: 8476747
[TBL] [Abstract][Full Text] [Related]
5. Regulation of expression of 3β-hydroxysteroid dehydrogenase is mediated by cAMP in rat Leydig cells and H540 rat Leydig tumor cells.
Keeney DS; Mason JI
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):915-22. PubMed ID: 22217836
[TBL] [Abstract][Full Text] [Related]
6. The structure of cDNA clones encoding the aromatase P-450 isolated from a rat Leydig cell tumor line demonstrates differential processing of aromatase mRNA in rat ovary and a neoplastic cell line.
Lephart ED; Peterson KG; Noble JF; George FW; McPhaul MJ
Mol Cell Endocrinol; 1990 Mar; 70(1):31-40. PubMed ID: 2340950
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms for regulation of 3 beta-hydroxysteroid dehydrogenase/delta 5----delta 4-isomerase, 17 alpha-hydroxylase/C17-20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells.
Payne AH; Sha LL
Endocrinology; 1991 Sep; 129(3):1429-35. PubMed ID: 1874181
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between ovarian aromatase cytochrome P450 and 5 alpha-reductase enzyme activities and mRNA levels during the estrous cycle in the rat.
Lephart ED; Doody KJ; McPhaul MJ; Simpson ER
J Steroid Biochem Mol Biol; 1992 Jun; 42(5):439-47. PubMed ID: 1616873
[TBL] [Abstract][Full Text] [Related]
9. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.
Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER
J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 aromatase in male germ cells.
Carreau S; Levallet J
Folia Histochem Cytobiol; 1997; 35(4):195-202. PubMed ID: 9619418
[TBL] [Abstract][Full Text] [Related]
11. Definition of the elements required for the activity of the rat aromatase promoter in steroidogenic cell lines.
Young M; McPhaul MJ
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):341-8. PubMed ID: 9365209
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the rat aromatase gene in ovarian granulosa cells and R2C Leydig cells.
Fitzpatrick SL; Richards JS
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):429-33. PubMed ID: 8476756
[TBL] [Abstract][Full Text] [Related]
14. Aromatase cytochrome P450 and cholesterol side-chain cleavage cytochrome P450 in corpora lutea of pregnant rats: diverse regulation by peptide and steroid hormones.
Hickey GJ; Oonk RB; Hall PF; Richards JS
Endocrinology; 1989 Sep; 125(3):1673-82. PubMed ID: 2759040
[TBL] [Abstract][Full Text] [Related]
15. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture.
Bulun SE; Simpson ER; Word RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):736-43. PubMed ID: 8126151
[TBL] [Abstract][Full Text] [Related]
16. cis-acting elements of the rat aromatase promoter required for cyclic adenosine 3',5'-monophosphate induction in ovarian granulosa cells and constitutive expression in R2C Leydig cells.
Fitzpatrick SL; Richards JS
Mol Endocrinol; 1993 Mar; 7(3):341-54. PubMed ID: 8387157
[TBL] [Abstract][Full Text] [Related]
17. Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells.
Lovekamp TN; Davis BJ
Toxicol Appl Pharmacol; 2001 May; 172(3):217-24. PubMed ID: 11312650
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunolocalization of functional cytochrome P450 aromatase in mature rat testicular cells.
Levallet J; Bilinska B; Mittre H; Genissel C; Fresnel J; Carreau S
Biol Reprod; 1998 Apr; 58(4):919-26. PubMed ID: 9546721
[TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of brain aromatase cytochrome P450.
Lephart ED
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):375-80. PubMed ID: 9365213
[TBL] [Abstract][Full Text] [Related]
20. A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase.
Heneweer M; van den Berg M; Sanderson JT
Toxicol Lett; 2004 Jan; 146(2):183-94. PubMed ID: 14643970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]